Evidence map›Paper›PMID 32123304›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2020

Features of endoscopic procedure site reaction associated with a recently approved submucosal lifting agent.

Carlos A Castrodad-Rodríguez, Nicole C Panarelli, Adam J Gersten, Qiang Liu, Michael Feely, Tony El Jabbour

Abstract read
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Carlos A Castrodad-RodríguezDepartment of Pathology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA.
Nicole C PanarelliDepartment of Pathology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA.
Adam J GerstenDepartment of Pathology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA.
Qiang LiuDepartment of Pathology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA.
Michael FeelyDepartment of Pathology, University of Florida, Gainesville, FL, USA.
Tony El JabbourDepartment of Pathology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA. teljabbour@montefiore.org.
Albert Einstein College of Medicine · USMontefiore Medical Center · USUniversity of Florida · US

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI THOMAS E ROHAN · 1985 to 2026
$111.2M
NCI NIH HHS P30 CA013330
6 · The paper itself

Abstract

Endoscopic resection techniques, such as endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD), are frequently aided by injection of submucosal lifting solutions that create a plane for dissection and protect deeper mural layers. ORISE™ gel is a recently approved synthetic lifting solution that produces a localized inflammatory reaction associated with retained gel at the injection site. We describe a series of six cases of ORISE™-associated inflammatory lesions in patients who underwent endoscopic resections. Deposits comprised pale fibrillary or hyalinized eosinophilic material, depending on their age. All cases were associated with an inflammatory reaction composed of foreign-body giant cells and scattered eosinophils. ORISE™ gel extended laterally and deeply beyond residual tumors in all cases. Histochemically, the material proved to be negative for Congo Red, and mucicarmine, faint blue with Alcian blue, but positive for PAS and PAS-D. It stained blue with trichrome. Such deposits were absent in cases, wherein other widely-available lifting solutions were used. We compared ORISE™ deposits to histologically similar extracellular deposits, namely amyloid and pulse granulomata. Unlike ORISE™ material, amyloid deposits appear as waxy, more densely eosinophilic material, and stain positive with Congo Red. Amyloid demonstrated prominent intramucosal and perivascular distributions, features not seen in this series of ORISE™ deposits. Hyalinized pulse granulomata showed strong overlap with ORISE™ deposits, since they also comprise eosinophilic material associated with giant cell reaction. On the other hand, they form ribbons of glassy material in circumscribed lobules, unlike the ill-defined ORISE™ deposits. In summary, we describe the pathologic findings at injection sites in patients who underwent endoscopic procedures aided by the recently approved lifting agent, ORISE™. Pathologists should be aware of its appearance and associated reaction to avoid confusion with other common extracellular deposits seen in the gastrointestinal tract.

Indexed as

AmyloidAgedAged, 80 and overEndoscopic Mucosal ResectionFemaleGelsGranulomaHumansMaleMiddle AgedPolymersAmyloidGelsPolymers

Identifiers

PMID32123304
OpenAlexW3010000679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.